PENUMBRA, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 210.9 USD | +0.32% |
|
-5.58% | -16.33% |
| Apr. 12 | Penumbra, Inc. : The underdog in healthcare |  |
| Mar. 28 | Nyrada Begins Good Laboratory Practice Preclinical Study for Brain Injury Drug Candidate | MT |
Presenter SpeechLawrence Biegelsen (Executives)Good morning. I'm Larry Biegelsen, the Medical ...
Cet article est réservé aux abonnés
Déjà abonné ?
Log InPas encore abonné ?
S'abonner
Penumbra, Inc. is a healthcare company. The Company designs, develops, manufactures, and markets products and has a portfolio that addresses challenging medical conditions in markets with unmet need. It is focused on developing, manufacturing, and marketing products for use by specialist physicians and healthcare providers to drive improved clinical and health outcomes. It is focused on developing and building its portfolio of products, including its thrombectomy, embolization, access, and immersive healthcare technologies. Common conditions that the Company focuses on Pulmonary Embolism, Deep Vein Thrombosis, Peripheral Arterial Occlusion, Ischemic Stroke, Acute Coronary Syndrome, Clot associated with Arteriovenous Graft or Fistula, Aneurysm, and Hemorrhagic Stroke. The Company sells its products to healthcare providers primarily through its direct sales organization in the United States, Europe, Canada and Australia, as well as through distributors in select international markets.
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
210.2
USD
Average target price
280.1
USD
Spread / Average Target
+33.25%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -16.33% | 8.14B | |
| +71.77% | 12.27B | |
| -3.70% | 5.37B | |
| +2.54% | 4.85B | |
| +22.66% | 4.38B | |
| -16.61% | 4.08B | |
| -40.06% | 2.29B | |
| +2.60% | 2.01B | |
| +0.48% | 1.8B | |
| -17.55% | 1.37B |
- Stock Market
- Equities
- PEN Stock
- News Penumbra, Inc.
- Transcript : Penumbra, Inc. Presents at 2022 Wells Fargo Healthcare Conference, Sep-07-2022 09
